Inventor · disambiguated record
Justin Roberts
Also filed as: ROBERTS JUSTIN · ROBERTS JUSTIN M
5 granted patents·3 pending applications·9 citations·filing 2016–2022
71Inventor score
Files withDANA FARBER CANCER INST INC8
Top patents by PatentIndex Score
8 records- 0191US11311609B2Regulating chimeric antigen receptorsDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 26, 2022·6 cites·29 claims
- 0286US11046954B2Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2018·Granted Jun 29, 2021·2 cites·17 claims
- 0374US10913752B2Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 9, 2021·1 cites·30 claims
- 0474US2022135967A1Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0571US2021301286A1Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responsesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0668US11293023B2Tunable endogenous protein degradationDANA FARBER CANCER INST INC·Filed 2018·Granted Apr 5, 2022·0 cites·13 claims
- 0761US2022119416A9Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0848US12023385B2Tunable endogenous protein degradation with heterobifunctional compoundsDANA FARBER CANCER INST INC·Filed 2018·Granted Jul 2, 2024·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Justin Roberts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →